CASI Pharmaceuticals (CASI) EPS (Basic) (2022 - 2025)
Historic EPS (Basic) for Pharmaceuticals (CASI) over the last 4 years, with Q2 2025 value amounting to -$0.7.
- Pharmaceuticals' EPS (Basic) fell 1162.25% to -$0.7 in Q2 2025 from the same period last year, while for Jun 2025 it was -$0.7, marking a year-over-year decrease of 1162.25%. This contributed to the annual value of -$14.87 for FY2024, which is 63617.34% down from last year.
- According to the latest figures from Q2 2025, Pharmaceuticals' EPS (Basic) is -$0.7, which was down 1162.25% from -$14.64 recorded in Q1 2025.
- In the past 5 years, Pharmaceuticals' EPS (Basic) ranged from a high of -$0.42 in Q3 2022 and a low of -$16.21 during Q4 2022
- For the 4-year period, Pharmaceuticals' EPS (Basic) averaged around -$4.48, with its median value being -$0.7 (2025).
- As far as peak fluctuations go, Pharmaceuticals' EPS (Basic) surged by 8991.92% in 2023, and later crashed by 227834.27% in 2024.
- Over the past 4 years, Pharmaceuticals' EPS (Basic) (Quarter) stood at -$16.21 in 2022, then skyrocketed by 89.92% to -$1.63 in 2023, then soared by 61.68% to -$0.63 in 2024, then decreased by 11.62% to -$0.7 in 2025.
- Its EPS (Basic) was -$0.7 in Q2 2025, compared to -$14.64 in Q1 2025 and -$0.63 in Q2 2024.